- Home
- CADL vs AMBC Comparison
CADL vs AMBC Comparison
Compare CADL & AMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- AMBC
- Stock Information
- Founded
- CADL 1999
- AMBC 1971
- Country
- CADL United States
- AMBC United States
- Employees
- CADL N/A
- AMBC N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- AMBC Property-Casualty Insurers
- Sector
- CADL Health Care
- AMBC Finance
- Exchange
- CADL Nasdaq
- AMBC Nasdaq
- Market Cap
- CADL 339.8M
- AMBC 392.1M
- IPO Year
- CADL 2021
- AMBC 1991
- Fundamental
- Price
- CADL $5.64
- AMBC $8.42
- Analyst Decision
- CADL Strong Buy
- AMBC Strong Buy
- Analyst Count
- CADL 7
- AMBC 1
- Target Price
- CADL $19.57
- AMBC $10.00
- AVG Volume (30 Days)
- CADL 841.7K
- AMBC 831.2K
- Earning Date
- CADL 11-14-2025
- AMBC 11-10-2025
- Dividend Yield
- CADL N/A
- AMBC N/A
- EPS Growth
- CADL N/A
- AMBC N/A
- EPS
- CADL N/A
- AMBC N/A
- Revenue
- CADL N/A
- AMBC $257,879,000.00
- Revenue This Year
- CADL N/A
- AMBC $3.54
- Revenue Next Year
- CADL N/A
- AMBC N/A
- P/E Ratio
- CADL N/A
- AMBC N/A
- Revenue Growth
- CADL N/A
- AMBC 148.44
- 52 Week Low
- CADL $3.79
- AMBC $5.99
- 52 Week High
- CADL $14.60
- AMBC $13.64
- Technical
- Relative Strength Index (RSI)
- CADL 51.71
- AMBC 47.82
- Support Level
- CADL $5.35
- AMBC $8.34
- Resistance Level
- CADL $5.80
- AMBC $8.74
- Average True Range (ATR)
- CADL 0.37
- AMBC 0.28
- MACD
- CADL -0.01
- AMBC 0.03
- Stochastic Oscillator
- CADL 42.40
- AMBC 61.90
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. It operates in two principal businesses segments: Insurance Distribution and Specialty Property & Casualty Insurance. Insurance Distribution segment includes Managing General Agents, Underwriters and other appointed and delegated underwriting businesses (collectively MGAs or MGA/Us), an insurance broker, and other distribution and underwriting businesses. Specialty Property & Casualty Insurance includes five carriers (collectively, Everspan). Key revenue is generated from Insurance Distribution.